FDA.reportPublic FDA data

denosumab-mobz 60 MG per 1 ML Prefilled Syringe

RxCUI
2729312
RxNorm name
denosumab-mobz 60 MG per 1 ML Prefilled Syringe
Display name
denosumab-mobz 60 MG per 1 ML Prefilled Syringe
Full name
denosumab-mobz 60 MG per 1 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761456Boncresadenosumab-mobz351(k) InterchangeableRx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
29140df2-24a3-4a6f-a8e3-065521448d61denosumab-mobz 60 MG in 1 ML Prefilled Syringe [PSN] · 1 ML denosumab-mobz 60 MG/ML Prefilled Syringe [SCD] · denosumab-mobz 60 MG per 1 ML Prefilled Syringe [SY] · denosumab-mobz 60 MG/ML per 1 ML Prefilled Syringe [SY]45These highlights do not include all the information needed to use BONCRESA safely and effectively. See full prescribing information for BONCRESA. BONCRESA ® (denosumab-mobz) injection, for subcutaneous use Initial U.S. Approval: 2010 BONCRESA (denosumab-mobz) is biosimilar* to PROLIA ® (denosumab)20251222